Congenital Heart Disease Carries a Shifting Mortality Burden in Preterm Infants
A large registry analysis has drawn a sharper boundary around how congenital heart disease changes the risk profile of premature birth. Among infants born at less than 35 weeks’ gestation, CHD was linked to a fourfold higher odds of in-hospital death, but the excess risk did not behave uniformly across gestational ages. At the earliest gestations, prematurity itself remained the dominant threat. As gestational age advanced, CHD increasingly became the driver of mortality and serious neonatal morbidity.
That pattern matters at the bedside.
The study pooled two North American neonatal registries spanning 2010 to 2022 and compared 11,221 infants with CHD from the Children’s Hospitals Neonatal Consortium with 720,846 infants without CHD from the Vermont Oxford Network. The primary outcome was in-hospital mortality, and secondary outcomes included major neonatal morbidities. This was not a small signal buried inside a narrow subgroup; it was a broad population-level comparison in which the effect of heart disease remained visible even against the background noise of prematurity itself.
Mortality Risk Was Highest Where Two Vulnerabilities Overlapped
The headline result was straightforward: preterm infants with CHD had significantly higher in-hospital mortality, with an odds ratio of 4.0 and a 95% confidence interval of 3.76 to 4.21. The magnitude of that association is hard to ignore, but the more clinically useful message lies in the gestational-age interaction. Mortality was similar at 26 weeks’ gestation or earlier, suggesting that at the most extreme end of prematurity, respiratory immaturity, fragile cerebral vasculature, and other consequences of being born so early may overwhelm the incremental burden of CHD. Beyond that point, the cardiac lesion begins to loom larger in the survival calculus.
This is biologically plausible. Very preterm infants already face limited pulmonary reserve, tenuous cerebral autoregulation, and immature gastrointestinal perfusion. CHD adds another layer: abnormal systemic or pulmonary blood flow, hypoxemia, altered preload and afterload, and a narrower margin for hemodynamic compensation. Even when the cardiac defect itself is not immediately catastrophic, the physiologic cost of maintaining circulation can compound the vulnerabilities of prematurity in a way that may not be obvious at delivery but becomes decisive over the course of the NICU stay.
The Relative Impact of CHD Rose as Gestation Increased
A notable feature of the analysis is the way CHD changed in relative importance across gestational strata. At the lowest gestational ages, prematurity dominated. With advancing gestation, the relative mortality impact of CHD increased. In practical terms, a 32-week infant with a serious cardiac lesion may enter the same unit with a different risk architecture than a 24-week infant, even if both are technically “preterm.” The heart defect carries proportionally more weight once the baseline hazards of extreme immaturity begin to recede.
That shift has consequences for counseling and planning. A neonatologist discussing prognosis with families cannot rely on gestational age alone to frame risk once CHD is part of the picture. The lesion, the timing of ductal dependency, and the anticipated need for intensive hemodynamic support all become part of the conversation. For delivery teams and cardiac services, the study reinforces the need to anticipate a changing risk profile rather than assuming that all preterm infants occupy the same prognostic category.
Severe BPD, IVH, and NEC Clustered With Cardiac Disease
Mortality was only part of the story. CHD was also associated with higher risks of severe bronchopulmonary dysplasia, intraventricular hemorrhage, and necrotizing enterocolitis. Those complications fit a coherent physiologic pattern. Abnormal oxygen delivery and systemic perfusion can aggravate lung injury, destabilize cerebral blood flow, and compromise intestinal oxygenation. In a preterm infant whose organs are still developing, the difference between marginal perfusion and sustained adequacy may be enough to determine whether lung disease progresses to severe BPD or whether intestinal vulnerability evolves into NEC.
The associations also make sense from a care-process standpoint. Infants with CHD often require more invasive monitoring, vasoactive support, respiratory manipulation, and prolonged critical care exposure. Each of those interventions may be necessary, but each also reflects the fragility of a circulation that is already operating close to its limits. The study does not claim causality for each morbidity, yet the pattern is consistent with the way mixed cardiopulmonary instability can propagate downstream organ injury in the neonatal intensive care unit.
Why This Matters for NICU Risk Stratification
The study’s most useful contribution is not merely the confirmation that CHD worsens outcome in preterm infants. It is the demonstration that the penalty is not fixed. A single gestational-age label does not capture the full hazard once congenital heart disease enters the equation. Risk is concentrated differently at 24 weeks than it is at 32 or 34 weeks, and the relative contribution of CHD grows as the infant becomes more mature at birth.
For clinical teams, that argues for more granular stratification. Delivery planning, early echocardiographic assessment, respiratory strategy, and surveillance for NEC or intracranial injury should all be tailored to the combined burden of prematurity and heart disease rather than to either condition in isolation. For families, the message is sobering but useful: survival and morbidity estimates depend not only on how early a baby is born, but also on whether the heart defect is likely to dominate the hospital course.
Registry Strengths and Data Boundaries
The scale of the analysis strengthens its credibility. More than 11,000 infants with CHD and more than 720,000 without CHD give the study enough breadth to detect differences across gestational strata rather than just in an overall average. The findings come from two established neonatal registries, which adds clinical relevance and reflects care delivered across a large North American network.
Still, the data are confined to in-hospital outcomes, and the study cannot resolve every lesion-specific question. The analysis shows how CHD shifts mortality and major morbidity in aggregate, but it does not replace defect-level risk prediction or explain which cardiac anatomies are most responsible for the gestational-age interaction. The data supporting the findings are not publicly available because of use and confidentiality restrictions, although access may be possible through the Children’s Hospitals Neonatal Consortium and Vermont Oxford Network with appropriate permission.
Even with those limits, the central message is difficult to miss: in preterm infants, CHD is not a uniform add-on diagnosis. Its impact changes with gestational age, and the consequences extend well beyond survival alone.